Gene Mutation Linked to Decision-Making Deficits in Schizophrenia

Researchers at the Massachusetts Institute of Technology (MIT) have identified a gene mutation that may explain why individuals with schizophrenia struggle to update their understanding of reality. The finding, announced on April 3, 2026, suggests that a specific mutation impairs the brain’s ability to integrate new information, leading to rigid and outdated thinking.

This inability to adapt to new information is known as a loss of cognitive flexibility. Over time, this deficit can make decision-making more difficult and contribute to a patient’s disconnect from reality.

The Role of the grin2a Gene

The mutation occurs in a gene called grin2a, which had been previously identified in large genetic studies of schizophrenia. This gene is responsible for encoding a protein for the NMDA receptor, a component located on the surface of neurons that reacts to the neurotransmitter glutamate.

According to research detailed by NeuroscienceNews, mutations in the grin2a gene significantly increase the risk of developing schizophrenia. These mutations disrupt the brain’s internal reality check by impairing the thalamocortical circuit.

In a neurotypical brain, new sensory input is used to update prior beliefs to match current reality. However, in brains affected by this mutation, the system over-weighs old beliefs and ignores new sensory input.

Impact on Brain Circuitry and Decision-Making

The researchers pinpointed the disruption to a key pathway between the thalamus and the prefrontal cortex. Specifically, the mutation impacts the mediodorsal thalamus, a region that communicates with the prefrontal cortex to regulate executive function and track the value of different choices.

To test this, scientists used mice with the grin2a mutation in a high-reward vs. Low-reward lever test. The researchers found that the mutant mice were significantly slower to switch their strategies when the effort required for a task changed.

This behavior demonstrates a failure in adaptive decision-making, as the mice continued to stick with outdated choices even after conditions had changed.

Potential for Therapeutic Reversal

The study also explored whether this cognitive rigidity could be reversed. By using optogenetics—a technique that uses light to artificially activate specific neurons—researchers were able to reactivate the affected thalamic circuit.

This intervention effectively reset the behavior of the mice, allowing them to make normal, adaptive decisions again. This discovery provides a concrete molecular target for future therapies aimed at treating the cognitive symptoms of schizophrenia.

If this circuit doesn’t work well, you cannot quickly integrate information

Guoping Feng, MIT

Research Methodology and Context

The identification of these mutations was made possible through a strategy known as whole-exome sequencing. Researchers at the Stanley Center used this method to reveal mutations that are often missed by other genetic studies, particularly those that only look at non-coding regions of the genome.

The findings build upon established research showing that people with schizophrenia often struggle with reward-based decision-making. By linking these behavioral deficits to a specific gene and brain circuit, the study offers a deeper understanding of the biological basis for the disorder’s cognitive symptoms.